Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Intimation of analyst meet
The Exchange has sought clarification from Dr Reddys Laboratories Ltd on September 17, 2026, with reference to news appeared in https://pharma.economictimes.indiatimes.com/ dated September 17, 2026 quoting "Dr Reddy''s gets voluntary licence for Gilead''s once-yearly HIV prevention drug"<BR><BR>The reply is awaited.
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Change in Senior Management Personnel
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Clarification- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulation, 2015
Scrutinizer''s Report
Outcome of 42nd Annual General Meeting
Copy of newspaper publication
Intimation of Earnings call recordings
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015- Conference Call Transcript
Intimation of Earnings call
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015